Christine Beeton

Title: Christine Beeton: Innovator in Autoimmune Disease Treatment

Introduction

Christine Beeton is a prominent inventor based in Pearland, TX (US), known for her significant contributions to the field of autoimmune disease treatment. With a total of 2 patents, she has made remarkable strides in developing therapeutic agents that target potassium channels.

Latest Patents

Her latest patents include innovative approaches such as potassium channel blockers and their use in treating autoimmune diseases. One notable patent discloses novel analogues of the sea anemone toxin ShK, which are designed to serve as therapeutic agents for autoimmune diseases. These analogues consist of a ShK toxin polypeptide and an N-terminal extension with a specific amino acid sequence. Another patent presents a scorpion toxin analogue, which is aimed at treating autoimmune diseases like multiple sclerosis (MS) and rheumatoid arthritis (RA). This analogue features a peptide with an amino acid substitution that enhances its selectivity for Kv1.3 over Kv1.1 and other potassium channels.

Career Highlights

Christine has worked with esteemed institutions such as Beijing University of Technology and Baylor College of Medicine. Her research has focused on the development of therapeutic agents that can effectively address the challenges posed by autoimmune diseases.

Collaborations

Throughout her career, Christine has collaborated with notable professionals, including Raymond S. Norton and Michael W. Pennington. These partnerships have contributed to her innovative research and the advancement of her patents.

Conclusion

Christine Beeton's work in the field of autoimmune disease treatment showcases her dedication to innovation and her impact on medical science. Her patents reflect a commitment to developing effective therapies that can improve the lives of those affected by autoimmune conditions.